View in EDS

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.

Saved in:
Bibliographic Details
Title: Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
Authors: Rutella S; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK.; Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, Nottinghamshire, UK., Cannarile MA; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Penzberg, Germany., Gnjatic S; Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Gomes B; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland., Guinney J; Sage Bionetworks, Seattle, Washington, USA., Karanikas V; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zurich, Switzerland., Karkada M; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA., Kirkwood JM; Department of Medicine, Division of Hematology/ Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Kotlan B; National Institute of Oncology, Budapest, Hungary., Masucci GV; Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Meeusen E; CancerProbe Pty Ltd, Prahran, Victoria, Australia., Monette A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Naing A; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thorsson V; Institute for Systems Biology, Seattle, Washington, USA., Tschernia N; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Wang E; Allogene Therapeutics, South San Francisco, California, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Wyant TL; Biolojic Design Inc, Cambridge, Massachusetts, USA., Cesano A; ESSA Pharma Inc, South San Francisco, California, USA acesano@essapharma.com.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33127656
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rutella+S%22">Rutella S</searchLink>; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK.; Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, Nottinghamshire, UK.<br /><searchLink fieldCode="AU" term="%22Cannarile+MA%22">Cannarile MA</searchLink>; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Gomes+B%22">Gomes B</searchLink>; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guinney+J%22">Guinney J</searchLink>; Sage Bionetworks, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Karanikas+V%22">Karanikas V</searchLink>; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Karkada+M%22">Karkada M</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kirkwood+JM%22">Kirkwood JM</searchLink>; Department of Medicine, Division of Hematology/ Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Kotlan+B%22">Kotlan B</searchLink>; National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Masucci+GV%22">Masucci GV</searchLink>; Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Meeusen+E%22">Meeusen E</searchLink>; CancerProbe Pty Ltd, Prahran, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Monette+A%22">Monette A</searchLink>; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Naing+A%22">Naing A</searchLink>; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Thorsson+V%22">Thorsson V</searchLink>; Institute for Systems Biology, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Tschernia+N%22">Tschernia N</searchLink>; Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Allogene Therapeutics, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wells+DK%22">Wells DK</searchLink>; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wyant+TL%22">Wyant TL</searchLink>; Biolojic Design Inc, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cesano+A%22">Cesano A</searchLink>; ESSA Pharma Inc, South San Francisco, California, USA acesano@essapharma.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2020 Oct; Vol. 8 (2).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33127656
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2020-001389
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rutella S
      – PersonEntity:
          Name:
            NameFull: Cannarile MA
      – PersonEntity:
          Name:
            NameFull: Gnjatic S
      – PersonEntity:
          Name:
            NameFull: Gomes B
      – PersonEntity:
          Name:
            NameFull: Guinney J
      – PersonEntity:
          Name:
            NameFull: Karanikas V
      – PersonEntity:
          Name:
            NameFull: Karkada M
      – PersonEntity:
          Name:
            NameFull: Kirkwood JM
      – PersonEntity:
          Name:
            NameFull: Kotlan B
      – PersonEntity:
          Name:
            NameFull: Masucci GV
      – PersonEntity:
          Name:
            NameFull: Meeusen E
      – PersonEntity:
          Name:
            NameFull: Monette A
      – PersonEntity:
          Name:
            NameFull: Naing A
      – PersonEntity:
          Name:
            NameFull: Thorsson V
      – PersonEntity:
          Name:
            NameFull: Tschernia N
      – PersonEntity:
          Name:
            NameFull: Wang E
      – PersonEntity:
          Name:
            NameFull: Wells DK
      – PersonEntity:
          Name:
            NameFull: Wyant TL
      – PersonEntity:
          Name:
            NameFull: Cesano A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2020 Oct
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1